针对免疫衰变来改善瘤免疫疗法
Zaoqu Liu1,2,3,4, Lulu Zuo5, Zhaokai Zhou6
1Department of Interventional Radiology The First Affiliated Hospital of Zhengzhou University Zhengzhou China.
MedComm
|October 30, 2024
概括
老龄化会损害免疫反应,增加癌症风险. 本综述探讨了免疫衰变机制和治疗方法,以增强瘤免疫疗法,并通过恢复免疫功能来改善患者的结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 老年学是一门学科.
背景情况:
- 瘤免疫疗法已经推进了癌症治疗.
- 免疫衰退,或与年龄相关的免疫衰退,损害了抗瘤反应.
- 这种下降增加了癌症的脆弱性,并影响了治疗的有效性.
研究的目的:
- 阐明免疫衰变的分子机制和标志.
- 探索免疫发生在瘤发生中的作用和瘤免疫微环境 (TIME).
- 评估当前和新兴的治疗策略,以对抗癌症免疫疗法中的免疫衰变.
主要方法:
- 检查免疫发生的分子,细胞,器官和疾病层面的变化.
- 分析与衰老相关的细胞外矩阵 (ECM) 贡献.
- 针对免疫性特征和免疫恢复的治疗策略的评估.
主要成果:
- 免疫发生涉及影响免疫系统的复杂分子和细胞变化.
- 与衰老相关的ECM修改可以影响瘤进展.
- 准免疫衰变为改善癌症免疫治疗提供了潜在的潜力.
结论:
- 了解免疫形成对于开发有效的癌症免疫疗法至关重要.
- 恢复老年人的免疫功能可以增强抗瘤免疫力.
- 未来的策略旨在通过解决免疫衰变来预防瘤的发展,复发和转移.
相关概念视频
Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
Cancer Vaccines
342
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cell-mediated Immune Responses
67.4K
Overview
67.4K


